Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | IBI3005 |
Synonyms | |
Therapy Description |
Limited information is currently available on IBI3005, a putative antibody-drug conjugate (ADC) (May 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IBI3005 | IBI-3005|IBI 3005 | Limited information is currently available on IBI3005, a putative antibody-drug conjugate (ADC) (May 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06418061 | Phase I | IBI3005 | Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors | Not yet recruiting | AUS | 0 |